Molecular detection of the G(-248)A BAX promoter nucleotide change in B cell chronic lymphocytic leukaemia

Journal of Clinical Pathology - Molecular Pathology

Volumn 56, Issue 4, 2003, Pages 205-209

  Moshynska, O ^a   Sankaran, K ^a   Saxena, A ^a  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; GUANINE; NUCLEOTIDE; PROTEIN BAX; RESTRICTION ENDONUCLEASE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; B LYMPHOCYTE; CANCER CELL CULTURE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTION; FEMALE; GEL ELECTROPHORESIS; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; LABORATORY; MALE; MOLECULAR DYNAMICS; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION MAPPING; SAMPLING; SEPARATION TECHNIQUE; SINGLE NUCLEOTIDE POLYMORPHISM;

5' UNTRANSLATED REGIONS; ADULT; AGED; AGED, 80 AND OVER; BCL-2-ASSOCIATED X PROTEIN; FEMALE; GENETIC MARKERS; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RESTRICTION MAPPING; SEQUENCE ANALYSIS, DNA;

EID: 0042067870     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.56.4.205     Document Type: Article

References (28)

1. Caligaris-Cappio F, Hamblin TJ. B-cell chronic lymphocytic leukemia: a bird of a different feather. J Clin Oncol 1999;17:399-408.
2. Molica S. Progression and survival studies in early chronic lymphocytic leukemia. Blood 1991;78:895-9.
3. Kipps TJ. Chronic lymphocytic leukemia. Curr Opin Hematol 1997;4:268-76.
4. Kay NE, Hamblin TJ, Jelinek DF, et al. Chronic lymphocytic leukemia: hematology 2002. American Society of Hematology Education Program Book. Washington, DC: American Society of Hematology, 2002:193-213.
5. Hamblin TJ, Davis Z, Gardiner A, et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848-54.
6. Krober A, Seiler T, Benner A, et al. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002;100:1410-16.
7. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840-7.
8. Oscier DG, Gardiner AC, Mould SJ, et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002;100:1177-84.
9. Domingo-Domenech E, Doming-Claros A, Gonzalez-Barca E, et al. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients. Haematologica 2002;87:1021-7.
10. Zupo S, Isnardi L, Megna M, et al. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemia with different responses to anti-IgM antibodies and propensity to apoptosis. Blood 1996;88:1365-74.
11. Bannerji R, Byrd JC. Update on the biology of chronic lymphocytic leukemia. Curr Opin Oncol 2000;12:22-9.
12. Pepper C, Hoy T, Bentley P. Elevated Bcl-2/Bax are a consistent feature of apoptosis resistance in B-cell chronic lymphocytic leukaemia and are correlated with in vivo chemoresistance. Leuk Lymphoma 1998;28:355-61.
13. Kitada S, Anderson J, Akar S, et al. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in viva chemoresponses. Blood 1998;91:3379-89.
14. Pepper C, Hoy T, Bentley DP. Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance. Br J Cancer 1997;76:935-8.
15. Osorio LM, De Santiago A, Aguilar-Santelises M, et al. CD6 ligation modulates the Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM. Blood 1997;89:2833-41.
16. Pepper C, Thomas A, Hoy T, et al. Antisense-mediated suppression of Bcl-2 highlights its pivotal role in failed apoptosis in B-cell chronic lymphocytic leukaemia. Br J Haematol 1999;107:611-15.
17. Pepper C, Thomas A, Hay T, et al. Antisense oligonucleotides complementary to Bax transcripts reduce the susceptibility of B-cell chronic lymphocytic leukaemia cells to apoptosis in a bcl-2 independent manner. Leuk Lymphoma 2002;43:2003-9.
18. Zha H, Aime Sempe C, Sara T, et al. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J Biol Chem 1996;271:7440-4.
19. Bodrug SE, Aime-Sempe C, Sato T, et al. Biochemical and functional comparisons of Mcl-1 and Bcl-2 proteins: evidence for a novel mechanism of regulating Bcl-2 family protein function. Cell Death Diff 1995;2:173-82.
20. Meijerink JP, Mensink EJBM, Wang K. Hematopoietic malignancies demonstrate loss-of-function mutations of bax. Blood 1998;91:2991-7.
21. Rampino N, Yamamoto H, Ionov Y, et al. Somatic frameshift mutations in the Bax gene in colon cancers of the microsatellite mutator phenotype. Science 1997;275:967-9.
22. Peng H, Aiello A, Packham G, et al. Infrequent bax gene mutations in B-cell lymphomas. J Pathol 1998;186:378-82.
23. Saxena A, Moshynska O, Sankaran K, et al. Association of a novel single nucleotide polymorphism, G(-248)A, in the 5′-UTR of BAX gene in chronic lymphocytic leukemia with disease progression and treatment resistance. Cancer Lett 2002;187:199-205.
24. Cheson BD, Bennett JM, Grever, et al. National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87:4990-7.
25. Harris NL, Jaffe ES, Stein H, et al. A revised European American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994;84:1361-92.
26. Rai KP, Patel DV. Chronic lymphocytic leukemia. In: Hoffman R, Benz EJ, Jr, Shattil SJ, et al. Hematology basic principles and practice, 3rd ed. Philadelphia: Churchill Livingstone, 2000:1350-62.
27. Ghia P, Guida G, Stella S, et al. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. Blood (online) 2002, Oct 24.
28. Thornhill AR, Snow K. Molecular diagnostics in preimplantation genetic diagnosis. J Mol Diagn 2002;4:11-29.